LOS ANGELES – AdvaMed Accel and MedTech Innovator announce that Sparta Biomedical is the winner of the 2023 MedTech Innovator Execution Award and the 2023 AdvaMed Accel Virginia Shimer Rybski Memorial Award. Both awards recognize the potential of an up-and-coming entrepreneur or entrepreneurial medical technology company and were presented during the AdvaMed Accel Leadership Seminar at the 2023 MedTech Conference in Anaheim.

Sparta Biomedical is developing the first-of-its-kind chemically engineered cartilage platform, Galene, to address the degeneration of cartilage between the joints, which can cause significant personal, economic, societal burden for individuals, families, and communities. 

“Small medical technology companies are at the forefront of innovation that improves patient care, and this year’s MedTech Innovator accelerator companies represent the very best our industry has to offer,” said DeChane Dorsey, executive director of AdvaMed Accel. “We are proud to recognize Sparta Biomedical with our 2023 award during The MedTech Conference to help them achieve their goals in developing life-improving care for patients living with osteoarthritis.”

“The Execution Award Competition celebrates high performers in achieving commercialization milestones on the path to market where they can positively impact patient lives,” said Paul Grand, CEO of MedTech Innovator. “Sparta Biomedical is executing well on its mission to treat osteoarthritis and get people moving without pain. We’re thrilled to recognize the Sparta Biomedical team for their exceptional accomplishments. We will continue to support all five of our 2023 finalists as they work tirelessly to improve human health.”

The MedTech Innovator Execution Award, presented jointly by AdvaMed Accel and MedTech Innovator, recognizes strong leadership teams with next-generation innovations and the resources to successfully execute on their goals of improving patient care.

The Virginia Shimer Rybski Memorial Award was created to encourage the enthusiastic pursuit of business excellence in the medical technology industry. It is named after the late entrepreneur and patient care advocate Virginia Rybski, president and CEO of Regenesis Biomedical and a member of AdvaMed’s Board of Directors and the association’s Accel Executive Committee, who passed away in 2013. The award is presented each year during the association’s annual meeting to a single presenting company or entrepreneur.

“It is an honor to be recognized and receive the 2023 Execution Award and the Virginia Shimer Rybski Memorial Award,” said Dushyanth Surakanti, CEO and Co-Founder of Sparta Biomedical. “These awards are going to help us in our goal of helping patients with osteoarthritis live pain free. Thank you to MedTech Innovator and AdvaMed for not only giving us this opportunity to showcase our work, but also for the recognition of these two awards.”

The MedTech Innovator competition has awarded more than $500,000 in cash prizes and in-kind awards so far in 2023. An additional $325,000 will be awarded at the two remaining competitions this year, taking place November 14-15, 2023, at the MedTech Strategist conference in San Francisco.

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry. Its mission is to improve patients’ lives by accelerating the growth of companies transforming the healthcare system. Since 2013, MedTech Innovator has reviewed more than 9,500 startups and graduated 613 companies that have gone on to raise more than $7.2 billion in follow-on funding and have brought 283 products to market.

For more information about MedTech Innovator, visit their website and follow them on LinkedIn and X (formerly Twitter).

About AdvaMed Accel

AdvaMed Accel is the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medical device and diagnostics manufacturers – the lifeblood of the medical technology industry. The only organization of its kind focusing specifically on the needs of the medtech industry’s emerging growth companies, AdvaMed Accel works to create a policy environment more conducive to capital formation and innovation. For more information, visit www.advamedaccel.org.

# # #